Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M de la Llera-Moya

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Journal of Nutrition|November 1, 1994
Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosisD W Morel, M de la Llera-Moya, K E Friday
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1992
Etoposide treatment suppresses atherosclerotic plaque development in cholesterol-fed rabbitsM de la Llera-Moya, G H Rothblat, J M Glick, et al.
Atherosclerosis|November 24, 1999
Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genesN Fournier, V Atger, J P Paul, et al.
Atherosclerosis|June 6, 2002
Cellular cholesterol flux studies: methodological considerationsG H Rothblat, M de la Llera-Moya, E Favari, et al.
Journal of Lipid Research|April 1, 1997
Modification of the cholesterol efflux properties of human serum by enrichment with phospholipidB Jian, M de la Llera-Moya, L Royer, et al.
Journal of Lipid Research|May 1, 1999
Cell cholesterol efflux: integration of old and new observations provides new insightsG H Rothblat, M de la Llera-Moya, V Atger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serumN Fournier, J L Paul, V Atger, et al.
The Journal of Clinical Investigation|February 15, 1997
Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cellsV M Atger, M de la Llera Moya, G W Stoudt, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1994
A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transferM de la Llera Moya, V Atger, J L Paul, et al.
The Journal of Clinical Investigation|December 1, 1995
Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AIV Atger, M de la Llera Moya, M Bamberger, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of Nutrition|November 1, 1994
Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosisD W Morel, M de la Llera-Moya, K E Friday
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1992
Etoposide treatment suppresses atherosclerotic plaque development in cholesterol-fed rabbitsM de la Llera-Moya, G H Rothblat, J M Glick, et al.
Atherosclerosis|November 24, 1999
Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genesN Fournier, V Atger, J P Paul, et al.
Atherosclerosis|June 6, 2002
Cellular cholesterol flux studies: methodological considerationsG H Rothblat, M de la Llera-Moya, E Favari, et al.
Journal of Lipid Research|April 1, 1997
Modification of the cholesterol efflux properties of human serum by enrichment with phospholipidB Jian, M de la Llera-Moya, L Royer, et al.
Journal of Lipid Research|May 1, 1999
Cell cholesterol efflux: integration of old and new observations provides new insightsG H Rothblat, M de la Llera-Moya, V Atger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serumN Fournier, J L Paul, V Atger, et al.
The Journal of Clinical Investigation|February 15, 1997
Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cellsV M Atger, M de la Llera Moya, G W Stoudt, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1994
A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transferM de la Llera Moya, V Atger, J L Paul, et al.
The Journal of Clinical Investigation|December 1, 1995
Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AIV Atger, M de la Llera Moya, M Bamberger, et al.
Pageof 2